Fosmanogepix
N/A
Report date: 2026/05/21 20:00:22
NMEFirst In ClassQIDP
Base Information
Drug NameFosmanogepix
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[7]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[22]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesEisai Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBasilea Pharmaceutica International LtdBasilea Pharmaceutica LtdBasilea Pharmaceutica +[6]
Inactive CompaniesN/A
Active Indications +[5]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A